Monaco Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GS
AA
DO
QCM
EAM
CGH
CUAMC
S
Monaco Asset Management's LKFT Position: Q2 2026 in Review
Monaco Asset Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 7% in Q2 2026, selling an estimated $54.5K and leaving 25,600 shares worth $767K. The position accounts for 0.06% of the portfolio, ranked #45.
Monaco Asset Management first reported a position in LKFT in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.35M in Q4 2021. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- Monaco Asset Management held 25,600 shares of Lakefront Biotherapeutics American Depositary Shares worth $767K as of Q2 2026.
- Monaco Asset Management sold 1,920 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $54.5K.
- Lakefront Biotherapeutics American Depositary Shares made up 0.06% of Monaco Asset Management's portfolio in Q2 2026, its #45 holding.
- Monaco Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2021 and has held it in 18 quarters since.
- Monaco Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $5.35M in Q4 2021.
- 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on Monaco Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.